Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testingWolff Schmiegel, Stephen B. Fox, Brian Draganic et al.|Molecular Oncology|2017Cited by 161
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, Amanda Psyrri, Aris Spathis et al.|Oral Oncology|2023Cited by 22
Blood-based testing of mutations in patients with head and neck squamous cell carcinoma (HNSCC) using highly sensitive SafeSEQ technologyFlorentia Fostira, Amanda Psyrri, P. Oikonomopoulou et al.|Annals of Oncology|2019Cited by 4